Medical Device News Magazine

itSpray Announces BOOSTit with New Ingredients Elderberry and Monk Fruit Coming Soon

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

February 8, 2021

itSpray founder Kimberly Stiele said, “At itSpray we strive to give you the best solutions for your total health needs. We continue to improve our products to help you pursue a healthier lifestyle with ease, including immune support, sustained energy, and sleep solutions. Which is why Drug Store News has named BOOSTit a Who’s Who of Immunity products.”

BOOSTit is a solution for immune support and contains many essential vitamins. These include vitamins A, C, D, B-12 and B2. These vitamins along with other natural ingredients, encourage white blood cell production and strengthen the immune system.

Elderberry (scientific name is sambucus), the first new ingredient in BOOSTit, comes from the European elder tree and is a type of flowering plant. According to Medical News Today, the dark purple berries and flowers contain many antioxidants that support the immune, including vitamin C, vitamin A, and iron. In addition to immune support, iron helps with energy, focus, digestion, and body temperature maintenance.

Monk fruit sweetener has replaced sucralose, the sweetener previously used in BOOSTit. Monk fruit, as defined by monkfruit.org, is a small, sub-tropical melon that has been cultivated for centuries. It is a super-fruit that acts as a natural sweetener. Monk fruit is able to provide a sweet flavor without the calories, and is rich in antioxidants. Since 2009, more than 800 products have used monk fruit sweetener. A few of the health benefits of monk fruit include weight loss, protection against diabetes, and immune support, according to Conserve Energy Future.

We expect a lot of interest in BOOSTit as our customers have been awaiting the arrival of the new formula. Your body works hard for you and will thank you for treating it with care it deserves.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”